Smith & Nephew Snats ADR (SNN) Stock Price, Quote & News

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization o...

Industry: Medical Devices

Sector: Healthcare

Phone: 44 1923 477 100

Website: www.smith-nephew.com

Address:

Building 5, Croxley Park Hatters Lane, Watford, United Kingdom

OfficialStocktwitsUser Mar. 19 at 3:49 PM

$SNN RSI: 21.64, MACD: -0.6088 Vol: 1.60, MA20: 34.73, MA50: 34.39 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Mar. 11 at 4:45 PM

$SNN launches ALLEVYN COMPLETE CARE — is this the game-changer for wound management? 🚀 📉 Shares dipped 2.9% after the news, but the new dressing could drive long-term growth with its innovative design and planned international expansion. Discover how this could impact SNN’s market position 👉 https://www.zacks.com/stock/news/2882519/snn-launches-allevyn-complete-care-dressing-for-wound-management?cid=sm-stocktwits-2-2882519-body-37023&ADID=SYND_STOCKTWITS_TWEET_2_2882519_BODY_37023

0 · Reply

ZacksResearch Mar. 11 at 3:45 PM

$SNN expands its wound care arsenal — and it could strengthen its position in a key market. 🩺 Smith + Nephew just launched the ALLEVYN COMPLETE CARE foam dressing for wound management, adding another product to its Advanced Wound Management portfolio. Discover what this launch could mean for the company 👉 https://www.zacks.com/stock/news/2882519/snn-launches-allevyn-complete-care-dressing-for-wound-management?cid=sm-stocktwits-2-2882519-teaser-37015&ADID=SYND_STOCKTWITS_TWEET_2_2882519_TEASER_37015

0 · Reply

SuperGreenToday Feb. 5 at 12:45 AM

$SNN Share Price: $35.10 Contract Selected: Sep 18, 2026 $40 Calls Buy Zone: $0.64 – $0.79 Target Zone: $1.20 – $1.47 Potential Upside: 77% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

OfficialStocktwitsUser Jan. 24 at 6:33 AM

$SNN RSI: 53.04, MACD: -0.0764 Vol: 0.54, MA20: 33.09, MA50: 32.96 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Jan. 19 at 6:04 PM

$SNN strengthens sports medicine with strategic acquisition! 💪 The acquisition of Integrity Orthopaedics adds cutting-edge technology to SNN's shoulder repair lineup, likely expanding its share and expected to improve profit margins by 2028 in the fast-growing RCR market. 📈 Discover the full impact of this move here 👉 https://www.zacks.com/stock/news/2819557/snn-boosts-shoulder-repair-portfolio-with-integrity-orthopaedics-deal?cid=sm-stocktwits-2-2819557-body-29540&ADID=SYND_STOCKTWITS_TWEET_2_2819557_BODY_29540

0 · Reply

ZacksResearch Jan. 19 at 5:04 PM

$SNN just made a strategic move to strengthen shoulder repair leadership 🦴📈 The company expanded its Sports Medicine portfolio with the Integrity Orthopaedics deal, adding next-gen Tendon Seam technology to boost its position in shoulder repair. See why this acquisition matters for SNN’s growth strategy 👉 https://www.zacks.com/stock/news/2819557/snn-boosts-shoulder-repair-portfolio-with-integrity-orthopaedics-deal?cid=sm-stocktwits-2-2819557-teaser-29516&ADID=SYND_STOCKTWITS_TWEET_2_2819557_TEASER_29516

0 · Reply

JHR Jan. 8 at 6:04 PM

$SNN aquire me. I need aquiring now. We give good price 👍 $RCEL

0 · Reply

BillionerOfKing Jan. 7 at 4:05 AM

$SNN Current Stock Price: $33.90 Contracts to trade: $35 SNN Jan 16 2026 Call Entry: $0.90 Exit: $1.50 ROI: 67% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser Dec. 24 at 3:32 PM

$SNN RSI: 50.18, MACD: -0.2782 Vol: 0.38, MA20: 32.88, MA50: 34.01 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC

Tue, 10 Mar 2026 10:30:00 -0400 - 11 days ago

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

2026-03-05T21:02:24.000Z - 16 days ago

Smith & Nephew (SNN) Sees Price Target Raised by Canaccord Genuity | SNN Stock News

2026-03-05T16:08:17.000Z - 16 days ago

Smith & Nephew PLC (SNN) Trading Down 4.28% on Mar 5

2026-03-04T01:04:30.000Z - 18 days ago

Smith & Nephew PLC (SNN) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...

2026-03-03T23:54:50.000Z - 18 days ago

Full Year 2025 Smith & Nephew PLC Earnings Call Transcript

Tue, 03 Mar 2026 13:00:00 -0500 - 18 days ago

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

Mon, 02 Mar 2026 13:00:00 -0500 - 19 days ago

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026

Mon, 02 Mar 2026 12:07:54 -0500 - 19 days ago

Smith & Nephew plc (SNN) Q4 2025 Earnings Call Transcript

2026-03-02T16:06:54.000Z - 19 days ago

Smith & Nephew PLC (SNN) Stock Price Down 4.72% on Mar 2

2026-03-02T13:11:55.000Z - 19 days ago

Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report

2026-03-02T07:56:46.000Z - 19 days ago

Smith & Nephew (SNN) Exceeds Q4 Revenue Expectations with Strong Growth

2026-03-02T07:45:39.000Z - 19 days ago

Smith & Nephew FY25 Results Rise, Lifts Dividend; Sees Growth Ahead

2026-03-02T07:30:20.000Z - 19 days ago

UK Stock Market News: Bunzl, Smith & Nephew, Sage

Mon, 02 Mar 2026 02:17:10 -0500 - 19 days ago

UK medical products maker Smith & Nephew's annual profit jumps 15.5%

2026-02-24T15:50:36.000Z - 25 days ago

Smith+Nephew Expands Portfolio with New U.S. Distribution Deal

Tue, 24 Feb 2026 10:28:00 -0500 - 25 days ago

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

2026-02-23T22:26:37.000Z - 26 days ago

Smith & Nephew (SNN) Strengthens Portfolio with SI-Bone Agreement

Mon, 23 Feb 2026 16:30:00 -0500 - 26 days ago

Smith+Nephew signs distribution agreement with SI-BONE

Wed, 21 Jan 2026 12:15:00 -0500 - 2 months ago

Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

Mon, 12 Jan 2026 12:34:38 -0500 - 2 months ago

UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million

Wed, 07 Jan 2026 22:47:30 -0500 - 2 months ago

Smith & Nephew: Improving And Undervalued, But Mind The Knees

Fri, 12 Dec 2025 11:32:53 -0500 - 3 months ago

Smith & Nephew plc (SNN) Analyst/Investor Day Transcript

Mon, 08 Dec 2025 02:22:48 -0500 - 3 months ago

Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets

Thu, 06 Nov 2025 07:16:10 -0500 - 4 months ago

Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript

Wed, 05 Nov 2025 09:58:08 -0500 - 4 months ago

Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release

Mon, 27 Oct 2025 11:30:00 -0400 - 5 months ago

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Wed, 22 Oct 2025 11:30:00 -0400 - 5 months ago

UFC® and Smith+Nephew announce multi-year extension of partnership

Fri, 03 Oct 2025 11:53:00 -0400 - 6 months ago

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

Wed, 01 Oct 2025 13:00:00 -0400 - 6 months ago

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Thu, 11 Sep 2025 08:00:00 -0400 - 6 months ago

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Wed, 03 Sep 2025 10:16:00 -0400 - 7 months ago

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

Thu, 07 Aug 2025 11:37:45 -0400 - 8 months ago

Smith & Nephew: Doing Better And Still Offers Value

Tue, 05 Aug 2025 10:06:02 -0400 - 8 months ago

Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript

Tue, 05 Aug 2025 09:11:23 -0400 - 8 months ago

Top 2 Health Care Stocks You May Want To Dump In Q3

Mon, 07 Jul 2025 10:00:00 -0400 - 9 months ago

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

$Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures$

Tue, 24 Jun 2025 10:00:00 -0400 - 9 months ago

Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures

Mon, 23 Jun 2025 08:00:00 -0400 - 9 months ago

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Wed, 18 Jun 2025 04:00:00 -0400 - 9 months ago

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Mon, 09 Jun 2025 10:00:00 -0400 - 10 months ago

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Tue, 27 May 2025 10:00:00 -0400 - 10 months ago

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Wed, 07 May 2025 08:00:00 -0400 - 11 months ago

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

Mon, 05 May 2025 02:00:00 -0400 - 11 months ago

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

Fri, 02 May 2025 17:42:04 -0400 - 11 months ago

Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript

Sat, 19 Apr 2025 22:09:29 -0400 - 1 year ago

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Thu, 03 Apr 2025 09:34:45 -0400 - 1 year ago

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

Tue, 11 Mar 2025 11:00:00 -0400 - 1 year ago

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Mon, 10 Mar 2025 11:00:00 -0400 - 1 year ago

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Thu, 06 Mar 2025 10:00:00 -0500 - 1 year ago

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Mon, 03 Mar 2025 08:20:00 -0500 - 1 year ago

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

OfficialStocktwitsUser Mar. 19 at 3:49 PM

0 · Reply

ZacksResearch Mar. 11 at 4:45 PM

0 · Reply

ZacksResearch Mar. 11 at 3:45 PM

0 · Reply

SuperGreenToday Feb. 5 at 12:45 AM

0 · Reply

OfficialStocktwitsUser Jan. 24 at 6:33 AM

0 · Reply

ZacksResearch Jan. 19 at 6:04 PM

0 · Reply

ZacksResearch Jan. 19 at 5:04 PM

0 · Reply

JHR Jan. 8 at 6:04 PM

$SNN aquire me. I need aquiring now. We give good price 👍 $RCEL

0 · Reply

BillionerOfKing Jan. 7 at 4:05 AM

0 · Reply

OfficialStocktwitsUser Dec. 24 at 3:32 PM

0 · Reply

BillionerOfKing Dec. 3 at 5:20 PM

$SNN Current Stock Price: $32.90 Contracts to trade: $35 SNN Dec 19 2025 Call Entry: $0.05 Exit: $0.07 ROI: 46% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JarvisFlow Nov. 11 at 6:18 PM

Canaccord Genuity updates rating for Smith & Nephew ( $SNN ) to Hold, target set at 36 → 34.

0 · Reply

SuperGreenToday Oct. 23 at 11:03 PM

$SNN Share Price: $36.49 Contract Selected: Mar 20, 2026 $35 Calls Buy Zone: $1.27 – $1.58 Target Zone: $2.08 – $2.54 Potential Upside: 54% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

MahiMe Oct. 22 at 5:35 PM

$SNN https://www.globenewswire.com/en/search/exchange/nyse,nasdaq?pagesize=10#:~:text=UFC%C2%AE%20and%20Smith%2BNephew%20announce%20multi%2Dyear%20extension%20of%20partnership UFC® and Smith+Nephew announce multi-year extension of partnership

0 · Reply

JarvisFlow Oct. 14 at 12:44 PM

Bernstein updates rating for Smith & Nephew ( $SNN ) to Market Perform, target set at 37.5.

0 · Reply

NVDAMillionaire Oct. 6 at 6:08 PM

$SNN Really good write-up that perfectly summarizes SNN's present situation. So if you want to bring your SNN knowledge up to date or just discover SNN, this is required reading. https://beyondspx.com/quote/SNN/analysis/smith-nephew-s-resurgent-growth-and-profitability-drive-nyse-snn

0 · Reply

30AMoney Sep. 5 at 6:05 PM

$SPY buy necessities such as health insurance $UNH & hip/knee replacements $SNN. just a thought...

0 · Reply

scottgrant2 Sep. 4 at 2:11 AM

$SNN please buy $RCEL their products could really help ur business and patients

0 · Reply

BringDownThoseReps Aug. 31 at 12:07 PM

$MDAI $MDT $SNN $TMO $GEHC

0 · Reply

thebestincredit Aug. 28 at 7:18 PM

$SNN my wife worked for this company for over 10 years and it’s a shit show now with new management. We were buying shares at discount for a few years and literally about to sell all right now at this price. GLTA

0 · Reply

JarvisFlow Aug. 18 at 12:30 PM

Canaccord Genuity has adjusted their stance on Smith & Nephew ( $SNN ), setting the rating to Hold with a target price of 28 → 36.

1 · Reply

30AMoney Aug. 5 at 3:30 PM

$SPY $SNN i'm taking some profits off the table!

1 · Reply

Market Cap	13.57B
Revenue (ttm)	6.16B
Net Income (ttm)	625.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	14.18
Profit Margin	10.14%
Debt to Equity Ratio	0.60

Volume	725,900
Avg Vol	923,168
Day's Range	N/A - N/A
Shares Out	424.91M
Stochastic %K	7%
Beta	0.62
Analysts	Sell
Price Target	$36.28